Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study

Autor: Danielle E. Altman, Xinke Zhang, An-Chen Fu, Alissa R. Rams, Jessica A. Baldasaro, Samir Ali Ahmad, Michael Schlichting, Patrick Marquis, Elena Benincasa, Camilo Moulin, Vivek Pawar

Publikováno v: Oncology and Therapy, Vol 11, Iss 2, Pp 231-244 (2023)

Abstract Introduction Small cell lung cancer (SCLC) is a subtype of lung cancer, the second most common cancer diagnosis worldwide. Currently, there is little published qualitative research that provides insight into the disease-related symptoms and

Externí odkaz: https://doaj.org/article/053a1049c64a491c9516cab45e4cd1cb

Larotaxel: broadening the road with new taxanes

Autor: Otto Metzger-Filho, Awada Ahmad, Evandro de Azambuja, Camilo Moulin

Publikováno v: Expert Opinion on Investigational Drugs. 18:1183-1189

Significant advances in cancer treatment have been achieved with novel targeted and state-of-the-art treatments. While the targeted treatments have received much attention in recent years, the more 'traditional' chemotherapeutic agents continue to pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1540db9422d6d777ead708101fd2065
https://doi.org/10.1517/13543780903119167

Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP)

Autor: Daphne De Jong, Evandro de Azambuja, Gedske Daugaard, Camilo Moulin, Ahmad Awada, Lieveke Ameye, Anne Møller, Lore Decoster, Jacques De Greve, Felipe Ades, Gustavo Ismael, Marianne Paesmans, Martine Piccart

Publikováno v: Vrije Universiteit Brussel
Journal of chemotherapy, 25(4), 239-246. Maney Publishing
Ades, F, de Azambuja, E, Daugaard, G, Ameye, L, Moulin, C, Paesmans, M, de Jong, D, Decoster, L, van Greve, J, Ismael, G, Moller, A K, Piccart, M & Awada, A 2013, ' Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP) ', Journal of chemotherapy, vol. 25, no. 4, pp. 239-246 . https://doi.org/10.1179/1973947813Y.0000000085

CupPrint® is a genomic signature able to identify 47 different cancer types. The aim of our study was to compare the accuracy of this genomic signature to that of a full clinical work-up in diagnosing the primary tumour site. Patients with newly dia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54db07e4a67790cc9d3ce944f84cd2ad
https://hdl.handle.net/20.500.14017/e6dbe031-95e3-450f-9f2c-42c54dbb6079

Changing the clinical picture of challenging tumors: tales becoming reality?

Autor: Otto Metzger-Filho, Camilo Moulin, Ahmad Awada

Publikováno v: Future oncology (London, England). 5(6)

The treatment of neoplastic diseases has become increasingly dependent on tumor biology and is focused on targeted therapy. Understanding complex networks of intracellular signaling pathways, blockades of specific targets and a myriad of other approa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64111533c2fb4cd4d74ba10e64a8d14c
https://pubmed.ncbi.nlm.nih.gov/19663729

The EORTC 10041/BIG 03–04 MINDACT (Microarray in Node Negative and 1 to 3 Positive Lymph Node Disease May Avoid ChemoTherapy) Trial: Patients' Baseline Characteristics and Logistics Aspects After a Successful Accrual

Autor: J-Y Pierga, Kristel Engelen, Jan Bogaerts, L van 't Veer, G. Viale, S. Delaloge, Ulrike Nitz, G. Werutsky, E.J.T. Rutgers, Isabel T. Rubio, Fatima Cardoso, M.J. Piccart, A. Thompson, Rodolfo Passalacqua, Camilo Moulin, Peter Vuylsteke

Publikováno v: European Journal of Cancer. 47:7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::87e97efbd1534f8bb2820e14ed8d2aed
https://doi.org/10.1016/s0959-8049(11)70109-5